Topics T cell mediated immunity Part II Effector

  • Slides: 27
Download presentation
Topics • T cell mediated immunity Part II – Effector T cells – Binding

Topics • T cell mediated immunity Part II – Effector T cells – Binding and secretion of effector molecules – CD 8 T cell function – CD 4 T cell function – Cytokines – TH 1 effector functions 1/19/2022 MICR 415 / 515 / 682 1

Effector T cells 1/19/2022 MICR 415 / 515 / 682 2

Effector T cells 1/19/2022 MICR 415 / 515 / 682 2

 • Adhesion molecules allow for longer cell-cell interaction • CD 4 cells bind

• Adhesion molecules allow for longer cell-cell interaction • CD 4 cells bind to target cells for a long time • CD 8 T cells bind to targets cells for short periods, kills target cell, then detaches and binds to another cell 1/19/2022 MICR 415 / 515 / 682 3

– Binding leads to clustering of receptors – Polarization: 1. Reorganization of cortical actin

– Binding leads to clustering of receptors – Polarization: 1. Reorganization of cortical actin cytoskeleton at site of contact 2. Reorientation of microtubule reorganizing center 3. Relocalization of Golgi apparatus 1/19/2022 x 4. Exocytosis at site of contact (tight space) – Detachment Fig 8. 28 MICR 415 / 515 / 682 4

Two types of effector molecules: 1. Cytotoxins 2. Cytokines Fig 8. 28 1/19/2022 MICR

Two types of effector molecules: 1. Cytotoxins 2. Cytokines Fig 8. 28 1/19/2022 MICR 415 / 515 / 682 5

Cytotoxins – Soluble secreted factors 1. perforin 2. granzyme – Membrane associated factors 1.

Cytotoxins – Soluble secreted factors 1. perforin 2. granzyme – Membrane associated factors 1. Fas Ligand 1/19/2022 MICR 415 / 515 / 682 6

Cytokines • Small secreted soluble molecules that can change the behavior or properties of

Cytokines • Small secreted soluble molecules that can change the behavior or properties of the cell itself or of another cell • Multiple effects in different types of cells • Synergism • Lymphocytes = lymphokines • T cell = Interleukines • Chemoattractants = chemokines • Studied by in vitro assays or gene disruption 1/19/2022 MICR 415 / 515 / 682 7

Types of effector T cells CTL Cytotoxic T cells CD 8 MHC I recognition

Types of effector T cells CTL Cytotoxic T cells CD 8 MHC I recognition Kill viral infected cells Kill Transformed cells Th 1 CD 4 MHC II recognition Activation of macrophages Th 2 CD 4 MHC II recognition Activation of B cells 1/19/2022 MICR 415 / 515 / 682 8

Effector Molecules 1/19/2022 MICR 415 / 515 / 682 9

Effector Molecules 1/19/2022 MICR 415 / 515 / 682 9

CD 8 T cells 1/19/2022 MICR 415 / 515 / 682 10

CD 8 T cells 1/19/2022 MICR 415 / 515 / 682 10

The kiss of death 1/19/2022 MICR 415 / 515 / 682 11

The kiss of death 1/19/2022 MICR 415 / 515 / 682 11

CTL effector molecules • Perforin: forms a pore in membrane • Granzymes: Serine proteases,

CTL effector molecules • Perforin: forms a pore in membrane • Granzymes: Serine proteases, activate apoptosis • Fas ligand: activates apoptosis • IFN- : inhibits viral replication, up-regulate MHC I expression, activates macrophages • TNF- : synergizes with IFN- , induce apoptosis 1/19/2022 MICR 415 / 515 / 682 12

Cytotoxic T cells are selective 1/19/2022 MICR 415 / 515 / 682 13

Cytotoxic T cells are selective 1/19/2022 MICR 415 / 515 / 682 13

CD 4 T cells TH 0 TH 1 1/19/2022 & TH 2 MICR 415

CD 4 T cells TH 0 TH 1 1/19/2022 & TH 2 MICR 415 / 515 / 682 14

Differentiation of CD 4 cells • Initial response mounted by the innate non-specific immune

Differentiation of CD 4 cells • Initial response mounted by the innate non-specific immune response is important in this process 1. Cytokines elicited by infectious agents 2. Molecules used for costimulation 3. Nature of MHC: peptide ligand 1/19/2022 MICR 415 / 515 / 682 15

Main Th 1 cytokines • IL-2 (Th 0, Th 1, CTL) – Growth of

Main Th 1 cytokines • IL-2 (Th 0, Th 1, CTL) – Growth of T cells – Growth of NK cells • IFN- (Th 1, CTL) – Increase MHC I & II – Inhibits Th 2 cell growth – Activates macrophages – B cell differentiation, Ig. G 2 a synthesis – Activates NK cells Figure 8: 31, appendix 2 1/19/2022 MICR 415 / 515 / 682 16

Main Th 2 cytokines • IL-4 (Th 2) – – – B cell activation

Main Th 2 cytokines • IL-4 (Th 2) – – – B cell activation and growth Th 2 growth and survival Increase MHC II Ig. G 1, Ig. E Decreases macrophage activation • IL-5 (Th 2) – Ig. A – increase eosinophils • IL-10 (Th 2) – Increase MHC II – Inhibit Th 1 cell growth 1/19/2022 MICR 415 / 515 / 682 17

other cytokines • IL-3 (Th 1, Th 2, CTL) – Stimulates hematopoiesis • TNF-

other cytokines • IL-3 (Th 1, Th 2, CTL) – Stimulates hematopoiesis • TNF- (Th 1, some Th 2, CTL) – Activates macrophages (synergy with IFN- ) – production of NO • GM-CSF (Th 1, Th 2, CTL) – Increase granulocyte production – Increase macrophage and dendritic cell production 1/19/2022 MICR 415 / 515 / 682 18

1/19/2022 MICR 415 / 515 / 682 19

1/19/2022 MICR 415 / 515 / 682 19

1/19/2022 MICR 415 / 515 / 682 20

1/19/2022 MICR 415 / 515 / 682 20

1/19/2022 MICR 415 / 515 / 682 21

1/19/2022 MICR 415 / 515 / 682 21

Consequences of Th 1 or Th 2 Leishmania sp Th 1 Th 2 Anti-IL-4

Consequences of Th 1 or Th 2 Leishmania sp Th 1 Th 2 Anti-IL-4 Resistant Susceptible Th 2 Th 1 Susceptible Resistant 1/19/2022 MICR 415 / 515 / 682 22

Macrophage activation • Requires 2 signals: • • • IFN -gamma CD 40 or

Macrophage activation • Requires 2 signals: • • • IFN -gamma CD 40 or membrane bound TNF alpha or beta • Stimulation via TCR triggers novo protein synthesis • Proteins are delivered to the site of contact by vesicles • Signals are delivered directly to that macrophage 1/19/2022 MICR 415 / 515 / 682 23

Activated macrophage 1. Increase fusion of lysosomes and phagosomes to form phagolysosomes 2. Increase

Activated macrophage 1. Increase fusion of lysosomes and phagosomes to form phagolysosomes 2. Increase oxygen radicals and Nitric Oxide production 3. Increase expression of B 7, CD 40, MHC II & TNF receptors 4. Production of IL-12 (stimulates Th 1 cells) 5. Recruitment of other cells 6. More effective killing 7. Better APC 1/19/2022 MICR 415 / 515 / 682 24

1/19/2022 MICR 415 / 515 / 682 25

1/19/2022 MICR 415 / 515 / 682 25

1/19/2022 MICR 415 / 515 / 682 26

1/19/2022 MICR 415 / 515 / 682 26

1/19/2022 MICR 415 / 515 / 682 27

1/19/2022 MICR 415 / 515 / 682 27